CBRI yields 2000000.00% · MRK yields 2.81%● Live data
📍 CBRI pulled ahead of the other in Year 1
Combined, CBRI + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CBRI + MRK for your $10,000?
CMTSU Liquidation, Inc. operates as an information technology (IT) service company worldwide. It operates as an independent software vendor or channel partner; and provides project management, application and technical consulting, and database administration for implementation projects and managed-services. The company also offers managed services; and enterprise application, IT strategy, and business process consultancy services, as well as project planning, systems implementation and integration, training and change management, and application management. Its application development and management/staffing services provide analysis, design, development, testing and quality assurance, implementation, and maintenance of its client's business applications. In addition, the company offers staffing services covering software development lifecycle, as well as steady-state operations; and sells various IT hardware and software products. It serves Global 2000 blue-chip companies in industries, such as manufacturing, retail, education, healthcare and life sciences, energy and utilities, financial services, and the public sector. The company was formerly known as Ciber, Inc. and changed its name to CMTSU Liquidation, Inc. in June 2017. CMTSU Liquidation, Inc. was founded in 1974 and is based in Denver, Colorado. On April 9, 2017, CMTSU Liquidation, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on December 20, 2018.
Full CBRI Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.